|
시장보고서
상품코드
2076242
당화 알부민 측정 시장 : 제품 유형별, 용도별, 최종사용자별, 지역별Glycated Albumin Assay Market, by Product Type, by Application, by End User, by Region |
||||||
당화 알부민 측정약 시장은 2026년에 7억 2,220만 달러 규모에 달할 것으로 추정되고 있으며, 2033년에 12억 6,210만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 8.3%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 7억 2,220만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 8.30% | 2033년 시장 규모 예측 : | 12억 6,210만 달러 |
당뇨병은 전 세계에서 유병률이 높은 만성 대사성 질환입니다. 당화 헤모글로빈(A1C)은 장기적인 혈당 모니터링의 기준 검사이며, 당뇨병의 만성 합병증과 관련이 있는 것으로 밝혀졌습니다. 그러나 헤모글로빈 대사에 영향을 미칠 가능성이 있는 임상 상황에서는 A1C 검사를 권장하지 않습니다.
당화 알부민(GA)은 단기적인 혈당 수치를 반영하는 검사이며, A1C 수치를 잘못 변화시킬 수 있는 상황의 영향을 받지 않습니다. 당화 알부민은 프럭토사민 중에서도 당화 정도가 높은 부분입니다. 표준화된 효소 분석법을 통해 측정되며, 간편하고 신속하게 수행할 수 있습니다.
시장 역학
시장의 주요 기업이 제품 포트폴리오를 확대하기 위해 기업 인수를 단행하는 등, 비유기적 성장 전략의 채택이 증가하고 있는 점이 예측 기간 중의 시장 성장을 촉진할 것으로 예상됩니다. 예를 들어 2021년 9월, 현장 진단(POC) 및 센트럴 랩용 기기를 제조하는 글로벌 의료기기 기업인 EKF는 제약, 생명공학, 의료기기 산업 분야에서 PCR 검사에 특화된 유명한 검사 기관인 Advanced Diagnostic Laboratory LLC의 인수를 완료했습니다.
또한 시장의 주요 기업이 제품 포트폴리오를 확대하기 위해 신제품을 출시하는 등 유기적 성장 전략을 채택하는 사례가 증가하고 있는 점도 예측 기간 중 시장 성장을 촉진할 것으로 예상됩니다. 예를 들어 2023년 1월 3일, 항체 및 시약의 주요 공급업체인 LifeSpan BioSciences Inc는 혈장 및 혈청 시료 내의 인간 당화 알부민을 정량적으로 검출하기 위한 96웰 효소면역측정법(ELISA) 키트 ‘ELISA Kit-LS-F15522'를 발매했습니다.
본 조사의 주요 특징 :
- 이 조사에서는 다양한 부문의 잠재적 매출 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하고 있는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 이 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 당화 알부민 분석 시장의 주요 기업 개요을 발표하고 있습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 관해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 이 '세계의 글리코알부민 측정 시장 보고서'는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 당화 알부민 측정 시장을 분석하는 데 사용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 당화 알부민 측정 시장 : 제품 유형별, 2021-2033년
제5장 세계의 당화 알부민 측정 시장 : 용도별, 2021-2033년
제6장 세계의 당화 알부민 측정 시장 : 최종사용자별, 2021-2033년
제7장 세계의 당화 알부민 측정 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSA 26.07.09Glycated Albumin Assay Market is estimated to be valued at USD 722.2 Mn in 2026 and is expected to reach USD 1,262.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 722.2 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.30% | 2033 Value Projection: | USD 1,262.1 Mn |
Diabetes mellitus is a chronic metabolic disease with a high incidence worldwide. Glycated hemoglobin (A1C) is the reference test for long-term glucose monitoring and has been shown to be associated with chronic complications of diabetes. However, A1C is not recommended in clinical situations that may affect hemoglobin metabolism.
The glycated albumin (GA) is a test that reflects short-term glycemia and is not influenced by situations that falsely alter A1C levels. Glycated albumin is the higher glycated portion of fructosamine. It is measured by a standardized enzymatic methodology, easy and fast to perform.
Market Dynamics
Increasing adoption of inorganic growth strategies, such as company acquisition by key players in the market to expand their product portfolio is expected to drive the market growth over the forecast period. For instance, in September 2021, EKF, a global medical manufacturer of Point-of-Care and Central Laboratory devices, completed the acquisition of Advanced Diagnostic Laboratory LLC, which is a well-known PCR-focused testing laboratory among the pharmaceutical, biotechnology and medical device communities.
The increasing adoption of organic growth strategies such as product launches by key players in the market to expand product portfolio is expected to drive the market growth over the forecast period. For instance, on 3 January 2023, LifeSpan BioSciences Inc, which is a leading provider of antibodies and reagents launched ELISA Kit-LS-F15522, which is a 96-well enzyme-linked immunosorbent assay (ELISA) for the Quantitative detection of human glycated albumin in samples of plasma and serum.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global glycated albumin assay market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study Asahi Kasei Pharma Corporation, Weldon Biotech, Inc., Abbexa Ltd., Laboratory Corporation of America, Biocompare, EFK Diagnostics, Elabscience Biotechnology Inc., Abbott, Diazyme Laboratories, Inc., Abnova Corporation, BSBE, Maccura Biotechnology Co.,Ltd., LifeSpan BioSciences, Inc., Biomatik, Geno Technology Inc., AMS Biotechnology (Europe) Limited, Epinex Diagnostics Inc., DxGen Corp.
- Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global glycated albumin assay report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global glycated albumin assay market.
Detailed Segmentation:
- Global Glycated albumin assay Market, By Product Type (Revenue, USD Mn, 2021 - 2033)
- Human Glycated Albumin Assay
- Animal Glycated Albumin Assay
- Global Glycated albumin assay Market, By Application (Revenue, USD Mn, 2021 - 2033)
- Diagnostics
- Prediabetes
- Type 1 Diabetes
- Type 2 Diabetes
- Research
- Others
- Global Glycated albumin assay Market, By End User (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Diagnostic Centers
- Research Centers
- Others
- Global Glycated albumin assay Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- By Country:
- U.S.
- Canada
- By Country:
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country:
- Europe
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Country:
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Country
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Country:
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- By Country/Region:
- Company Profiles
- Asahi Kasei Pharma Corporation*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Weldon Biotech, Inc.
- Abbexa Ltd.
- Laboratory Corporation of America
- Biocompare
- EFK Diagnostics
- Elabscience Biotechnology Inc.
- Abbott
- Diazyme Laboratories, Inc.
- Abnova Corporation
- BSBE
- Maccura Biotechnology Co.,
- LifeSpan BioSciences, Inc.
- Biomatik
- Geno Technology Inc.
- AMS Biotechnology (Europe) Limited
- Epinex Diagnostics Inc
- DxGen Corp
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Product Launches
- Merger, Acquisition, Collaborations
- Regulatory Guideline and Compliances
- Key Developments
- PEST Analysis
- Technology Landscape
- PORTER's Analysis
- Pricing Analysis (2022)
4. Global Glycated Albumin Assay Market , By Product Type, 2021-2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Human Glycated Albumin Assay
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Animal Glycated Albumin Assay
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
5. Global Glycated Albumin Assay Market , By Application, 2021-2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segments Trends
- Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Prediabetes
- Type 1 Diabetes
- Type 2 Diabetes
- Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
6. Global Glycated Albumin Assay Market , By End User, 2021-2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segments Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Research Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
7. Global Glycated Albumin Assay Market , By Region, 2021-2033, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021-2033, (US$ Million)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Asahi Kasei Pharma Corporation*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Weldon Biotech, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbexa Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Laboratory Corporation of America
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Biocompare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- EFK Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Elabscience Biotechnology Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbot
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Diazyme Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abnova Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BSBE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Maccura Biotechnology Co.,Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- LifeSpan BioSciences, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Biomatik
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Geno Technology Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AMS Biotechnology (Europe) Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Epinex Diagnostics Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- DxGen Corp
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
